摘要
基质金属蛋白酶(MMP)是一组锌依赖性金属内肽酶,负责细胞外基质成分的降解,修复和重塑。 MMP在维持正常的生理功能和预防疾病(例如癌症和心血管疾病)中起着重要作用。源自植物的天然产物已经用作传统药物已有数百年历史了。它的活性化合物(例如儿茶素,白藜芦醇和槲皮素)作为MMPs抑制剂发挥着重要作用,从而为它们在许多领域的应用打开了新的见解,例如制药,化妆品和食品工业。这篇综述总结了具有MMP调节活性的植物来源的天然产物的当前知识。大多数审查的植物来源的产品表现出对MMPs的抑制活性。在MMP中,对MMP-2和MMP-9的研究最多。 MMPs的表达通过相应的信号通路(例如MAPK,NF-κB和PI3激酶通路)被抑制,这有助于减少癌细胞行为(例如增殖和迁移)。大多数研究都采用了体外模型,但仅进行了有限的动物研究和临床试验。即使植物来源的产品在调节MMP方面显示出可喜的成果,但仍需要更多的体内研究和临床试验来支持其未来的治疗应用。
关键词: 抗癌,细胞外基质,基质金属蛋白酶,MMP,天然产物,植物,肿瘤。
图形摘要
Current Cancer Drug Targets
Title:Modulation of Matrix Metalloproteinases by Plant-derived Products
Volume: 21 Issue: 2
关键词: 抗癌,细胞外基质,基质金属蛋白酶,MMP,天然产物,植物,肿瘤。
摘要: Matrix metalloproteinases (MMPs) are a group of zinc-dependent metalloendopeptidases that are responsible for the degradation, repair, and remodeling of extracellular matrix components. MMPs play an important role in maintaining a normal physiological function and preventing diseases, such as cancer and cardiovascular diseases. Natural products derived from plants have been used as traditional medicine for centuries. Its active compounds, such as catechin, resveratrol and quercetin, are suggested to play an important role as MMPs inhibitors, thereby opening new insights into their applications in many fields, such as pharmaceutical, cosmetic, and food industries. This review summarises the current knowledge of plant-derived natural products with MMP-modulating activities. Most of the reviewed plant-derived products exhibit an inhibitory activity on MMPs. Amongst MMPs, MMP-2 and MMP-9 are the most studied. The expression of MMPs is inhibited through respective signaling pathways, such as MAPK, NF-κB and PI3 kinase pathways, which contribute to the reduction in cancer cell behaviors, such as proliferation and migration. Most studies have employed in vitro models, but a limited number of animal studies and clinical trials have been conducted. Even though plant-derived products show promising results in modulating MMPs, more in vivo studies and clinical trials are needed to support their therapeutic applications in the future.
Export Options
About this article
Cite this article as:
Modulation of Matrix Metalloproteinases by Plant-derived Products, Current Cancer Drug Targets 2021; 21 (2) . https://dx.doi.org/10.2174/1568009620666201120144838
DOI https://dx.doi.org/10.2174/1568009620666201120144838 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The FKBP51-Glucocorticoid Receptor Balance in Stress-Related Mental Disorders
Current Molecular Pharmacology Angiogenesis and Blood-Brain Barrier Permeability in Vascular Remodeling after Stroke
Current Neuropharmacology Actively Targeted Nanoparticles for Drug Delivery to Tumor
Current Drug Metabolism Glutamate Transporter 1: Target for the Treatment of Alcohol Dependence
Current Medicinal Chemistry The Disposal of Reactive Carbonyl Species through Carnosine Conjugation: What We Know Now
Current Medicinal Chemistry Breast Cancer: Current Developments in Molecular Approaches to Diagnosis and Treatment
Recent Patents on Anti-Cancer Drug Discovery Anti-inflammatory and Immune Therapy for Alzheimers Disease: Current Status and Future Directions
Current Neuropharmacology Somatostatin, Somatostatin Analogs and Somatostatin Receptor Dynamics in the Biology of Cancer Progression
Current Molecular Medicine Suramin: Clinical Uses and Structure-Activity Relationships
Mini-Reviews in Medicinal Chemistry Receptor Tyrosine Kinases as Therapeutic Targets in Malignant Glioma
Reviews on Recent Clinical Trials A Brief Review of the Essential Role of Nanovehicles for Improving the Therapeutic Efficacy of Pharmacological Agents Against Tumours
Current Drug Delivery Antigenic Differences Between Normal and Malignant Cells as a Basis for Treatment of Intracerebral Neoplasms Using a DNA-Based Vaccine
Current Genomics iNOS: A Potential Therapeutic Target for Malignant Glioma
Current Molecular Medicine Novel Agents in CNS Myeloma Treatment
Central Nervous System Agents in Medicinal Chemistry Editorial [Hot Topic: Development of Drugs Interfering with Apoptosis (Executive Guest Editor: Sebastiano Cavallaro)]
Current Pharmaceutical Design A New Aspect of the TrkB Signaling Pathway in Neural Plasticity
Current Neuropharmacology Understanding Cancer Drug Resistance by Developing and Studying Resistant Cell Line Models
Current Cancer Drug Targets Subject Index to Volume 4
Current Genomics 5'-Nucleotidases, Nucleosides and their Distribution in the Brain: Pathological and Therapeutic Implications
Current Medicinal Chemistry The Biology of TRAIL and the Role of TRAIL-Based Therapeutics in Infectious Diseases
Anti-Infective Agents in Medicinal Chemistry